Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/autre/biopatent-law-european-vs-us-patent-law/descriptif_2789540
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=2789540

Biopatent Law: European vs. US Patent Law, 2014 SpringerBriefs in Biotech Patents Series

Langue : Anglais

Auteurs :

Couverture de l’ouvrage Biopatent Law: European vs. US Patent Law

SpringerBriefs in Biotech Patents presents timely reports on intellectual properties (IP) issues and patent aspects in the field of biotechnology. This volume focus on particular aspects of the US patent law, which can have tremendous differences compared to the European law. This includes questions of biopatent prosecution, novelty, inventive step, written disclosure and sufficiency of enablement as well as questions of law enforcement of biotech patents.

Preface.- Ulrich Storz: Patentability Requirements of Biotech Patents.- Martin Quodbach: Law Enforcement of Biotech Patents.- Scott D. Marty, Derek E. Constantine and Matthew Parker: Particular: Aspects of US Patent Law in Biotechnologies.- About the Authors.

Addresses currently debated issues concerning biotechnological inventions

Written by internationally active experts

Provides a basis for understanding biotech patentability

Includes supplementary material: sn.pub/extras

Date de parution :

Ouvrage de 69 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

63,29 €

Ajouter au panier

Thème de Biopatent Law: European vs. US Patent Law :